Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study.

Autor: Alvarado D; Celldex Therapeutics, Hampton, New Jersey, USA., Maurer M; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universtätsmedizin Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany., Gedrich R; Celldex Therapeutics, Hampton, New Jersey, USA., Seibel SB; Celldex Therapeutics, Hampton, New Jersey, USA., Murphy MB; Celldex Therapeutics, Hampton, New Jersey, USA., Crew L; Celldex Therapeutics, Hampton, New Jersey, USA., Goldstein J; Celldex Therapeutics, Hampton, New Jersey, USA., Crocker A; Celldex Therapeutics, Hampton, New Jersey, USA., Vitale LA; Celldex Therapeutics, Hampton, New Jersey, USA., Morani PA; Celldex Therapeutics, Hampton, New Jersey, USA., Thomas LJ; Celldex Therapeutics, Hampton, New Jersey, USA., Hawthorne TR; Celldex Therapeutics, Hampton, New Jersey, USA., Keler T; Celldex Therapeutics, Hampton, New Jersey, USA., Young D; Celldex Therapeutics, Hampton, New Jersey, USA., Crowley E; Celldex Therapeutics, Hampton, New Jersey, USA., Kankam M; Altasciences Clinical Kansas, Overland Park, Kansas, USA., Heath-Chiozzi M; Celldex Therapeutics, Hampton, New Jersey, USA.

Publikováno v: Allergy [Allergy] 2022 Aug; Vol. 77 (8), pp. 2393-2403. Date of Electronic Publication: 2022 Mar 03.